Koninklijke Philips N.V. stock (NL0000009538): Ex-dividend date set for May 14

Koninklijke Philips N.V. is set to trade ex-dividend on May 14, 2026, with shareholders of record on May 13, 2026 eligible to receive the upcoming dividend distribution, according to Futunn News as of May 12, 2026. This dividend event represents a key date for income-focused investors holding the Amsterdam-listed healthcare company.

The stock has experienced recent volatility, with shares trading at €21.96 on May 13, 2026, reflecting a 4.15% decline as upward momentum stalled, according to market data. On the New York Stock Exchange, the company trades under the ticker PHG, providing US investors direct access to the diversified healthcare manufacturer.

As of: May 13, 2026

By the editorial team – specialized in equity coverage.

Koninklijke Philips N.V.: core business model

Koninklijke Philips operates as a diversified global healthcare company structured around three primary segments. The diagnosis and treatment segment accounts for nearly 50% of total revenue and encompasses imaging systems, ultrasound equipment, and image-guided therapy solutions used in hospitals and diagnostic centers worldwide. This segment serves as the company's largest revenue contributor and reflects its deep expertise in medical imaging and interventional technologies.

The connected care segment focuses on remote monitoring and patient management solutions, while the personal health division addresses consumer wellness products. This three-pillar structure positions Philips as both a business-to-business healthcare technology provider and a consumer health brand, creating diversified revenue streams across institutional and retail channels.

Main revenue and product drivers for Koninklijke Philips N.V.

Imaging and diagnostic equipment represent the cornerstone of Philips' institutional revenue, with ultrasound systems and image-guided interventional tools serving as critical tools in modern healthcare delivery. These products command premium pricing in developed markets and represent recurring revenue opportunities through service contracts and consumables. The diagnosis and treatment segment's dominance reflects sustained global demand for advanced diagnostic capabilities in hospitals and specialized clinics.

Connected care solutions address the growing trend toward remote patient monitoring and telehealth, particularly relevant in aging populations across developed economies. Personal health products, including consumer-grade monitoring devices and wellness equipment, tap into the expanding consumer health and fitness market. Together, these segments create a balanced portfolio with exposure to both institutional healthcare spending and consumer discretionary health trends.

Financial guidance and market position

Koninklijke Philips maintained its full-year 2026 outlook for comparable sales growth of 3% to 4.5% and adjusted EBITDA margin of 12.5% to 13%, according to Insider Monkey as of May 2026. This guidance reflects management confidence in the company's ability to navigate market conditions while maintaining profitability targets. The free cash flow outlook remains a key metric for dividend sustainability and capital allocation decisions.

Conclusion

Koninklijke Philips N.V. approaches a significant dividend date on May 14, 2026, marking an important event for income-oriented shareholders. The company's maintained guidance for 2026 suggests management confidence despite recent stock price volatility. US investors with exposure through the NYSE-listed PHG ticker should monitor upcoming earnings reports and capital allocation decisions to assess the sustainability of dividend distributions and long-term value creation.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.